Jim McPherson
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Jim McPherson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.
2
| Subsidiary | Financial Conglomerates | 2 |
Cenexi Services SAS
Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jim McPherson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cenexi SAS
Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Phinex SAS
Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Financial Conglomerates | Chairman | |
Delpharm Industrie SAS
Delpharm Industrie SAS BiotechnologyHealth Technology Delpharm Industrie SAS engages in the manufacture and development of CDMO drugs. It produces dosage forms, non-sterile and sterile liquids, solids, semi-solids and biotech products. The company was founded in 1988 and is headquartered in Boulogne-Billancourt, France. | Biotechnology | Chief Executive Officer | |
Cenexi - Laboratoires Thissen SA
Cenexi - Laboratoires Thissen SA Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year. | Pharmaceuticals: Major | Director/Board Member | |
Cenexi Hsc SAS
Cenexi Hsc SAS Pharmaceuticals: MajorHealth Technology Cenexi HSC SAS is a French company founded in 2004 that specializes in the development and manufacturing of sterile and biological products. The company is based in Fontenay-sous-Bois, France. The company's services include formulation, analytical and galenic development, industrial transfer, and regulatory support. | Pharmaceuticals: Major | Chairman | |
Cenexi 2 SASU
Cenexi 2 SASU Pharmaceuticals: MajorHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cenexi 2 SASU is a contract manufacturing and development organization of pharmaceutical products. The company is based in Fontenay-sous-Bois, France. The French company was founded in 2016. The CEO is Christophe Durand. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Frankreich | 6 |
Belgien | 2 |
Sektoral
Health Technology | 6 |
Finance | 2 |
Operativ
Chief Executive Officer | 4 |
Director/Board Member | 2 |
Chairman | 2 |
President | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Christophe Durand | 6 |
Alain Kirchmeyer | 3 |
- Börse
- Insiders
- Jim McPherson
- Unternehmensverbindungen